- Home
- VERU vs NXN Comparison
VERU vs NXN Comparison
Compare VERU & NXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VERU | NXN |
|---|---|---|
| Founded | 1971 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.8M | 47.6M |
| IPO Year | 1990 | N/A |
Fundamental Metrics
Financial Performance| Metric | VERU | NXN |
|---|---|---|
| Price | $2.19 | $12.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | ★ 174.8K | 9.7K |
| Earning Date | 12-17-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $48.42 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.11 | $10.64 |
| 52 Week High | $14.20 | $12.45 |
Technical Indicators
Market Signals| Indicator | VERU | NXN |
|---|---|---|
| Relative Strength Index (RSI) | 37.58 | 49.56 |
| Support Level | $2.23 | $11.90 |
| Resistance Level | $2.49 | $12.18 |
| Average True Range (ATR) | 0.18 | 0.09 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 10.91 | 71.42 |
Price Performance
Historical ComparisonAbout VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.